d.tamm
TL2 Moderator · Aalborg
Contributes reviews on supplier material. Based in Aalborg.
Joined 11 January 2025 · last posted 6d
74Posts here
0Topics
1Solutions
164Likes received
115Likes given
17Badges
100Days visited
839Posts read
Recent activity
Full stream-
Submitting a sample: the process end to end Replied, post #102 · Sourcing › Independent verification · 22 Jul 2026 · 0 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Common supplements people ask about, assessed one at a time Replied, post #31 · Practice › Interactions · 10 Jul 2026 · 6 likes post #30 answers the question as asked. The question underneath it is different. Supplements and herbs: many have no established interaction. Some do. If you are taking…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #5 · Practice › Interactions · 2 Jul 2026 · 8 likes This follows post #2 rather than contradicting it. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #41 · Analytics › Home & field testing · 27 Jun 2026 · 0 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #27 · Start Here › Welcome · 17 Jun 2026 · 3 likes post #26 is right about the mechanism and I think understates the practical bit. Welcome. The orientation materials are pinned at the top of this category and they take…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #2 · Practice › Dosing & titration · 17 Jun 2026 · 10 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #74 · Practice › Administration · 14 Jun 2026 · 12 likes post #73 answers the question as asked. The question underneath it is different. Drawing up with one needle and injecting with another: a reasonable practice if you…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #25 · Compounds › Oral incretins · 11 Jun 2026 · 8 likes Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual variation is larger than with injectables and is…
-
Second pass at: Programming during a large energy deficit Replied, post #10 · Nutrition & Training › Resistance training · 1 Jun 2026 · 19 likes On post #6 — agreed on the reasoning, with one qualification. Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #3 · Access › Insurance & coverage · 1 Jun 2026 · 3 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
-
Semaglutide and alcohol: what is actually documented Replied, post #6 · Compounds › Semaglutide · 28 May 2026 · 0 likes Worth separating two things that post #2 runs together. On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide…
-
Journal club: LEADER as the historical anchor Replied, post #80 · Evidence › Journal club · 27 May 2026 · 4 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…